ReviewBlood advances2020

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.

Alexander Neuwelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.